Chimerix announces emergency IND applications for brincidofovir authorized by FDA to treat Ebola
These requests were made by treating physicians. Emergency Investigational New Drug Applications (EIND) were granted by the U.S. Food and Drug Administration (FDA). "Chimerix is committed to working